These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38971472)

  • 21. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells.
    Baltrons MA; García A
    J Neurochem; 1999 Nov; 73(5):2149-57. PubMed ID: 10537075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitric oxide and cyclic GMP are involved in angiotensin II AT(2) receptor effects on neurite outgrowth in NG108-15 cells.
    Gendron L; Côté F; Payet MD; Gallo-Payet N
    Neuroendocrinology; 2002 Jan; 75(1):70-81. PubMed ID: 11810036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of NO/cGMP pathway in the antidepressant-like effect of gabapentin in mouse forced swimming test.
    Ostadhadi S; Kordjazy N; Haj-Mirzaian A; Ameli S; Akhlaghipour G; Dehpour A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):393-402. PubMed ID: 26753696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of nitric oxide signaling pathway mediates hypotensive effect of Muntingia calabura L. (Tiliaceae) leaf extract.
    Shih CD; Chen JJ; Lee HH
    Am J Chin Med; 2006; 34(5):857-72. PubMed ID: 17080550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that brain nitric oxide synthase is the major nitric oxide synthase isoform in the hypothalamus of the adult female rat and that nitric oxide potently regulates hypothalamic cGMP levels.
    Bhat G; Mahesh VB; Aguan K; Brann DW
    Neuroendocrinology; 1996 Aug; 64(2):93-102. PubMed ID: 8857603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of repeated sublethal ischemia on NO/cGMP signal transduction system in gray matter of the rabbit spinal cord.
    Pavel J; Lukacova N; Marsala J
    Bratisl Lek Listy; 2001; 102(6):273-7. PubMed ID: 11725390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nitric oxide synthase and cGMP in the anterior pituitary gland: effect of a GnRH antagonist and nitric oxide donors.
    Yamada K; Xu ZQ; Zhang X; Gustafsson L; Hulting AL; de Vente J; Steinbusch HW; Hökfelt T
    Neuroendocrinology; 1997 Feb; 65(2):147-56. PubMed ID: 9067993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracerebroventricular administration of nitric oxide-sensitive guanylyl cyclase inhibitors induces catalepsy in mice.
    Echeverry MB; Salgado ML; Ferreira FR; da-Silva CA; Del Bel EA
    Psychopharmacology (Berl); 2007 Oct; 194(2):271-8. PubMed ID: 17593355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice.
    Dhir A; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):921-5. PubMed ID: 17379375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pituitary adenylate cyclase-activating polypeptide stimulates nitric-oxide synthase type I expression and potentiates the cGMP response to gonadotropin-releasing hormone of rat pituitary gonadotrophs.
    Garrel G; Lozach A; Bachir LK; Laverriere JN; Counis R
    J Biol Chem; 2002 Nov; 277(48):46391-401. PubMed ID: 12244042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressant-like effect of nitric oxide synthase inhibitors and sildenafil against lipopolysaccharide-induced depressive-like behavior in mice.
    Tomaz VS; Cordeiro RC; Costa AM; de Lucena DF; Nobre Júnior HV; de Sousa FC; Vasconcelos SM; Vale ML; Quevedo J; Macêdo D
    Neuroscience; 2014 May; 268():236-46. PubMed ID: 24662848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of nitric oxide/cyclic GMP and cyclic AMP in beta3 adrenoceptor-chronotropic response.
    Sterin-Borda L; Bernabeo G; Ganzinelli S; Joensen L; Borda E
    J Mol Cell Cardiol; 2006 Apr; 40(4):580-8. PubMed ID: 16510153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human soluble guanylate cyclase as a nitric oxide sensor for NO-signalling reveals a novel function of nitrite reductase.
    Pan J; Xu Q; Lin YW; Zhong F; Tan X
    Chem Commun (Camb); 2013 Aug; 49(67):7454-6. PubMed ID: 23864033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium ferulate attenuates anoxia/reoxygenation-induced calcium overload in neonatal rat cardiomyocytes by NO/cGMP/PKG pathway.
    Chen HP; Liao ZP; Huang QR; He M
    Eur J Pharmacol; 2009 Jan; 603(1-3):86-92. PubMed ID: 19087873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of cyclic GMP-dependent vasodilators on the expression of inducible nitric oxide synthase in vascular smooth muscle cells: role of cyclic AMP.
    Boese M; Busse R; Mülsch A; Schini-Kerth V
    Br J Pharmacol; 1996 Oct; 119(4):707-15. PubMed ID: 8904645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of beta3 adrenergic receptor decreases DNA synthesis in human skin fibroblasts via cyclic GMP/nitric oxide pathway.
    Furlán C; Sterin-Borda L; Borda E
    Cell Physiol Biochem; 2005; 16(4-6):175-82. PubMed ID: 16301818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-specific expression and immunolocalization of nitric oxide synthase isoforms and the related nitric oxide/cyclic GMP signaling pathway in the ovaries of neonatal and immature rats.
    Zhang W; Wei QW; Wang ZC; Ding W; Wang W; Shi FX
    J Zhejiang Univ Sci B; 2011 Jan; 12(1):55-64. PubMed ID: 21194187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Nitric oxide/CGMP/KATP pathway mediates systemic and central antinociception induced by resistance exercise in rats.
    Galdino GS; Xavier CH; Almeida R; Silva G; Fontes MA; Menezes G; Duarte ID; Perez AC
    Int J Neurosci; 2015; 125(10):765-73. PubMed ID: 25271801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of nNOS/NO/sGC/cGMP signaling pathway in cocaine sensitization and in the associated hippocampal alterations: does phosphodiesterase 5 inhibition help to drug vulnerability?
    Gabach LA; Carlini VP; Monti MC; Maglio LE; De Barioglio SR; Perez MF
    Psychopharmacology (Berl); 2013 Sep; 229(1):41-50. PubMed ID: 23579428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
    Dhir A; Kulkarni SK
    Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.